Stéphane Bancel, Moderna CEO, said in an interview with Bloomberg's Romaine Bostick, that he believes the personalized mRNA cancer vaccine his company is developing with Merck & Co. will work in a variety of tumors, directly addressing a key issue shrouding the company’s future. 

St&eacute;phane Bancel, Moderna CEO, said in an interview with Bloomberg's Romaine Bostick, that he believes the personalized mRNA cancer vaccine his company is developing with Merck &amp; Co. will work in a variety of tumors, directly addressing a key issue shrouding the company&rsquo;s future.&nbsp;

Listen for top interviews from Bloomberg News. 

Hear conversations with the biggest names in finance, politics, technology, foreign relations, sports and entertainment.

Listen for top interviews from Bloomberg News. Hear conversations with the biggest names in finance, politics, technology, foreign relations, sports and entertainment.

Listen to top interviews from Bloomberg News.

Bloomberg Talks

Moderna CEO Stéphane Bancel Talks Vaccine Collaboration With Merck

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/41499e95-ea54-4879-a2bb-b4ef016b7649/transcript